click below
click below
Normal Size Small Size show me how
icsnihyap
Mosby Paramedic 3rd Ed. - Ch 17 Pharmacology Terms
| Question | Answer |
|---|---|
| Absorption | The process by which drug molecules are moved from the site of entry into the body into the general circulation. |
| Adrenergic | Of or pertaining to the sympathetic nerve fibers of the autonomic nervous system, which use epinephrine or epinephrine-like substances as neurotransmitters. |
| Agonists | Drugs that combine with receptors and initiate the expected response. |
| Antagonists | Agents designed to inhibit or counteract the effects of other drugs or undesired effects caused by normal or hyperactive physiological mechanisms. |
| Anticholinergic | Of or pertaining to the blocking of acetylcholine receptors, resulting in inhibition of transmission of parasympathetic nerve impulses. |
| Biological Half-life | The time required to metabolize or eliminate half the total amount of a drug in the body. |
| Biotransformation | The process by which a drug is converted chemically to a metabolite. |
| Chemical Name | The exact designation of a chemical structure as determined by the rules of chemical nomenclature. |
| Cholinergic | Of or pertaining to the effects produced by the parasympathetic nervous system or drugs that stimulate or antagonize the parasympathetic nervous system. |
| Contraindications | Medical or physiological factors that make it harmful to administer a medication that would otherwise have a therapeutic effect. |
| Controlled Substance | Any drug defined in the categories of the Comprehensive Drug Abuse Prevention and Control Act of 1970. |
| Cumulative action | The effect that occurs when several doses of a drug are administered or when absorption occurs more quickly than removal by excretion or metabolism or both. |
| Distribution | The transport of a drug through the bloodstream to various tissues of the body and ultimately to its site of action. |
| Drug | Any substance take by mouth; Injected into a muscle, blood vessel, or cavity of the body; or applied topically to treat or prevent a disease or condition. |
| Drug interaction | Modification of the effects of one drug by the previous or concurrent administration of another drug, thereby increasing or diminishing the pharmacological or physiological action of one or both drugs. |
| Drug Receptors | Parts of a cell with which a drug molecule interacts to trigger its desired response or effect. |
| Excretion | The elimination of toxic or inactive metabolites primarily by the kidneys; the intestines, lungs, and mammary, sweat, and salivary glands also may be involved. |
| First-pass Metabolism | The initial biotransformation of a drug during passage through the liver from the portal vein that occurs before the drug reaches the general circulation. |
| Generic Name | The official, established name assigned to a drug. |
| Idiosyncrasy | An abnormal or peculiar response. |
| Loading Dose | A large quantity of drug that temporarily exceeds the capacity of the body to excrete the drug. |
| Maintenance Dose | The amount of a drug required to keep a desired steady state of drug concentration in tissues. |
| Official Name | The name of a drug that is followed by the initials USP or NF, denoting its listing in one of the official publications, usually the same as the generic name. |
| Parenteral | Of or pertaining to any medication route other than the alimentary canal. |
| Pharmaceutics | The science of dispensing drugs. |
| Pharmacodynamics | The study of how a drug acts on a living organism. |
| Pharmacokinetics | The study of how the body handles a drug over a period of time, including the process of absorption, distribution, biotransformation, and excretion. |
| Placental Barrier | A protective biological membrane that separates the blood vessels of the mother and the fetus. |
| Potentiation | The enhancement of the effect of a drug, caused by concurrent administration of two drugs in which one drug increases the effect of the other. |
| Summation | The combined effects of two drugs that equal the sum of the individual effects of each agent. |
| Synergism | The combined action of two drugs that is greater than the sum of each agent acting independently. |
| Therapeutic action | The desired, intended action of a drug. |
| Therapeutic index | A measurement of the relative safety of a drug. |
| Tolerance | A physiological response that requires that a drug dosage be increased to produce the same effect formerly produced by a smaller dose. |
| Trade Name | the trademark name of a drug, designated by the drug company that sells the medication. |
| Untoward Effects | Side effects that prove harmful to the patient. |
| Adrenergic Agents | Stimulate the Sympathetic Nervous System, proveds the effects of epinephrine and norepinephrine when given. |
| Adrenergic Responses | Stimulation and inhibition of the Sympathetic Nervous System |
| Alpha 1 and 2 Effects | Vasoconstriction of the systemic blood vessels, mild broncho-constriction, no cardiac effects, activation of secretory glands. |
| Beta 1 Effects | Increased heart rate, increased contractile force of the myocardium, increased automaticity in the heart. |
| Beta 2 Effects | Vasodilation of the systemic blood vessels, bronchodilation. Inhibits secretory action of salivary glands. |
| Sympathomimetic | Drugs producing effects which mimic the actions of the sympathetic nervous system. |
| Catecholamines | Adrenergic agents with catechol nucleus as basic molecular structure. (Norepinephrine, epinephrine, isoproterenol) |
| Sympathetic or Beta Blocker | Blocks effects of the sympathetic nervous system. |
| Cholinergic Agents | Stimulate the parasympathetic providing cholinergic effects. |
| Parasympathomimetics | Drugs which mimic the actions of the parasympathetic nervous system. |
| Parasympathetic Blocker, Parasympatholytic, Vogolytic | Block actions of the parasympathetic nervous system particularly to Vagus nerve. |